Get the full picture
Sign in to uncover key details.
Kiromic
Business Services · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
7707 Fannin St Ste 140, Houston, Texas, ...Phone Number
(832) 968-4888Website
www.kiromic.comRevenue
<$5 MillionStock Symbol
KRBPIndustry
About Kiromic
Kiromic BioPharma, Inc. is a clinical-stage, fully integrated biotherapeutics company using its proprietary DIAMOND AI (artificial intelligence) platform to discover, validate and develop celland gene therapies with a therapeutic focus on immuno-oncology. Kiromic is in the process of developing ALEXIS, a multi-indication allogeneic CAR-T cell therapy platform that exploits the natural potency of gamma delta T-cells to target solid cancers. Kiromic's DIAMOND AI is where data science meets target identification to dramatically compress the years and millions of dollars required to develop a cellular therapeutic. The Company maintains offices in Houston, Texas.Explore more
SIC Code 87,873NAICS Code 54,541Ticker OTC: KRBPShow moreKiromic Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Kiromic
Compare insights from companies similar to Kiromic, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Kiromic Tech Stack
A closer look at the technologies used by Kiromic
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Kiromic
Sign Up For FreeTo access detailed company insights
Kiromic BioPharma, Inc. is a clinical-stage, fully integrated biotherapeutics company using its proprietary DIAMOND AI (artificial intelligence) platform to discover, validate and develop celland gene therapies with a therapeutic focus on immuno-oncology. Kiromic is in the process of developing ALEXIS, a multi-indication allogeneic CAR-T cell thera... Read More
